Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cyclopharm Ltd (CYC.AX)

Cyclopharm Ltd (CYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cyclopharm Ltd Unit 4, 1 The Crescent Kingsgrove Sydney NSW 2208 AUS

https://cyclopharm.com.au P: +61 295410411 F: +61 295430960

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism, and distributor of products to the diagnostic imaging sector. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment.

Key Statistics

Overview:

Market Capitalization, $K 85,633
Shares Outstanding, K 120,611
% of Institutional Shareholders 0.12%

Financials:

Annual Sales, $ 27,573 K
Annual Net Income, $ -13,198 K

Growth:

1-Year Return -47.86%
3-Year Return -51.33%
5-Year Return -70.45%
5-Year Revenue Growth 14.39%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.12
Annual Dividend & Yield (Fwd) 0.01 (0.00%)
Most Recent Dividend 0.005 on 09/01/23
Next Ex-Dividends Date 09/01/23
Dividend Payable Date 09/11/23
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 05/28/12

CYC.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -31.98%
Return-on-Assets % -22.29%
Profit Margin % -47.87%
Debt/Equity 0.18
Price/Sales 4.82
Price/Book 3.16
Book Value/Share 0.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar